Residency · Residency · Oral Maxillofacial Surgery
Office-Based Anesthesia in OMFS: Standards and Safety
Introduction
The OMFS specialty has a long and distinguished history of providing office-based anesthesia for ambulatory surgical procedures. This capability is a defining feature of the specialty, with OMFS being the only dental specialty that provides deep sedation and general anesthesia in the office setting. Maintaining the highest standards of safety requires rigorous training, appropriate equipment, team preparedness, and adherence to regulatory standards.
Historical Context
OMFS pioneered office-based anesthesia in dentistry beginning in the 1940s and 1950s. The specialty has maintained an exceptional safety record through self-regulation, standardized training, and continuous quality improvement. The AAOMS Office Anesthesia Evaluation (OAE) program has been the gold standard for office inspection since 1975. The OMFS office anesthesia safety record stands at approximately 1 death per 365,000 anesthetics, which is comparable to or better than hospital-based anesthesia.
Regulatory Framework
AAOMS Standards
The AAOMS Parameters of Care define the minimum standards for office-based anesthesia. All OMFS offices providing deep sedation or general anesthesia must undergo OAE inspection every 5 years. Requirements include documented emergency protocols, drug inventory, equipment maintenance, and staff certifications.
State Regulations
State dental boards regulate the permits required for sedation and anesthesia. Permit levels typically correspond to minimal sedation (anxiolysis), moderate sedation, and deep sedation or general anesthesia. Requirements vary by state and may include facility inspection, continuing education, and morbidity/mortality reporting.
Personnel Requirements
A minimum of three appropriately trained team members must be present during deep sedation or general anesthesia: the surgeon/anesthetist, a surgical assistant, and a dedicated monitoring assistant (circulator). At least one team member besides the surgeon must hold current BLS certification, and ACLS certification is strongly recommended for the surgeon and monitoring assistant.
Facility Requirements
Physical Plant
The operatory must be of adequate size to accommodate the patient, surgical team, and emergency equipment. A dedicated recovery area with monitoring capability is required. A reliable emergency power source (backup generator or battery), adequate lighting and ventilation, and ADA-compliant accessibility are all necessary.
Equipment Standards
The anesthesia delivery system includes calibrated flowmeters, vaporizers (if using inhalational agents), or a TIVA setup. Minimum monitoring equipment includes continuous pulse oximetry, continuous capnography/end-tidal CO2 (mandatory for deep sedation and general anesthesia), continuous electrocardiography, automated non-invasive blood pressure measurement at least every 5 minutes, a precordial or pretracheal stethoscope, and temperature monitoring capability. Two independent suction sources are required. Oxygen delivery includes pipeline or cylinder O2 with a backup E-cylinder supply.
Emergency Preparedness
Emergency Equipment
Essential emergency equipment includes a positive-pressure ventilation device (self-inflating bag-valve-mask with reservoir), a laryngoscope with multiple blade sizes (Macintosh and Miller), endotracheal tubes in a range of sizes (5.0-8.0), supraglottic airway devices (laryngeal mask airway), oral and nasal airways in multiple sizes, suction catheters (Yankauer and flexible), a defibrillator/AED, and IV access supplies with syringes and emergency drugs.
Emergency Drug Kit
| Drug | Concentration/Form | Indication |
|---|---|---|
| Epinephrine | 1:1,000 (IM) and 1:10,000 (IV) | Anaphylaxis; cardiac arrest |
| Atropine | 0.5-1 mg IV | Symptomatic bradycardia |
| Diphenhydramine | 25-50 mg IV/IM | Allergic reaction |
| Hydrocortisone/Dexamethasone | 100 mg IV / 4-8 mg IV | Allergic reaction; adrenal crisis |
| Nitroglycerin | 0.4 mg SL tablet/spray | Angina; acute coronary syndrome |
| Albuterol | MDI inhaler | Bronchospasm |
| Flumazenil | 0.2 mg IV (titrate) | Benzodiazepine reversal |
| Naloxone | 0.4 mg IV/IM (titrate) | Opioid reversal |
| Succinylcholine | 1 mg/kg IV | Laryngospasm (if GA administered) |
| Dantrolene | 2.5 mg/kg IV | Malignant hyperthermia (may be at designated nearby facility) |
| 50% Dextrose | 25-50 mL IV | Hypoglycemia |
| Aspirin | 325 mg PO (chewed) | Acute coronary syndrome |
| Labetalol/Hydralazine | 10-20 mg IV | Hypertensive emergency |
The emergency drug kit must include epinephrine (1:1000 and 1:10,000), atropine, diphenhydramine, hydrocortisone or dexamethasone, nitroglycerin, an albuterol inhaler, flumazenil (benzodiazepine antagonist), naloxone (opioid antagonist), succinylcholine (if administering general anesthesia), dantrolene availability (for malignant hyperthermia, which may be at a designated nearby facility), 50% dextrose, aspirin, and antihypertensives (labetalol, hydralazine).
Emergency Drills
Regular simulation drills should be conducted at least annually, with quarterly drills recommended. Scenarios should include anaphylaxis, bronchospasm, cardiac arrest, laryngospasm, malignant hyperthermia, and local anesthetic systemic toxicity. All team members must know their roles in each emergency scenario. Debriefing and documentation follow each drill.
Patient Selection and Preoperative Assessment
Patient selection is guided by the ASA Physical Status Classification.
| ASA Class | Definition | Office-Based Anesthesia Suitability |
|---|---|---|
| ASA I | Healthy, no systemic disease | Appropriate |
| ASA II | Mild systemic disease, no functional limitation | Appropriate |
| ASA III | Severe systemic disease with functional limitation | May be appropriate with careful risk-benefit analysis |
| ASA IV | Severe systemic disease, constant threat to life | Hospital or ASC setting required |
| ASA V | Moribund, not expected to survive without surgery | Hospital setting only |
ASA I and II patients are appropriate for office-based anesthesia. ASA III patients may be appropriate with careful risk-benefit analysis. ASA IV patients and above should be managed in a hospital or ambulatory surgery center setting. A thorough medical history, medication review, and focused physical examination are performed. NPO guidelines require 2 hours for clear liquids, 6 hours for a light meal, and 8 hours for a full meal. Informed consent is documented, covering risks, benefits, and alternatives to anesthesia.
Documentation and Quality Improvement
The anesthesia record must document vital signs at regular intervals, drugs administered (dose, time, route), airway management, fluid administration, and adverse events. A time-based anesthesia record with entries at minimum every 5 minutes is required. Discharge criteria include a Modified Aldrete score of 9 or above, a responsible adult escort, and written post-operative instructions. Participation in AAOMS morbidity and mortality reporting programs, quality assurance reviews, and peer evaluation are all integral to maintaining the safety record.
Clinical Pearls
The safety of office-based anesthesia in OMFS depends on rigorous adherence to standards, proper equipment, and well-trained teams. Capnography is mandatory for deep sedation and general anesthesia and is the earliest indicator of airway compromise. Regular emergency simulation drills are essential because the team must be prepared for rare but critical events. Patient selection using ASA classification helps identify those best suited for the office versus hospital setting. Comprehensive documentation protects both the patient and the practitioner.
References
- American Association of Oral and Maxillofacial Surgeons. AAOMS Parameters of Care: Clinical Practice Guidelines for Oral and Maxillofacial Surgery (AAOMS ParCare). 6th ed. 2017.
- Perrott DH, Yuen JP, Andresen RV, Dodson TB. Office-based ambulatory anesthesia: outcomes of clinical practice of oral and maxillofacial surgeons. J Oral Maxillofac Surg. 2003;61(9):983-995.
- Bouloux GF, Punnia-Moorthy A. Manual of office-based anesthesia procedures. Oral Maxillofac Surg Clin North Am. 2013;25(3):399-412.
- Boynes SG. Dental anesthesiology: past, present, and future. Anesth Prog. 2014;61(3):107-108.